| Taylor Bailey, | |
|
115 Commons Way, Oxford, AL 36203-3483 | |
| (256) 835-4080 | |
| Not Available |
| Full Name | Taylor Bailey |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 115 Commons Way, Oxford, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952881559 | NPI | - | NPPES |
| 20554 | Other | LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 20554 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Taylor Bailey, 44164 Us Highway 78, Unit 202, Lincoln, AL 35096 Ph: () - | Taylor Bailey, 115 Commons Way, Oxford, AL 36203-3483 Ph: (256) 835-4080 |
News Archive
Sipuleucel-T (Provenge), an experimental immunotherapy improved survival in men with metastatic disease, according to new results to be presented April 28 at the American Urological Association (AUA) Annual Scientific Meeting in Chicago.
An antibody-based treatment can gently and effectively eliminate diseased blood-forming stem cells in the bone marrow to prepare for the transplantation of healthy stem cells, according to a study in mice by researchers at the Stanford University School of Medicine.
USHIFU, LLC (US HIFU), a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies and manufacturer of the Sonablate® 500 (Sonablate) medical device, announces the acquisition of certain Misonix HIFU assets and European distribution rights. In addition, through its transaction with Misonix, US HIFU acquires the Sonatherm® 600 medical device, a laparoscopic HIFU system used to ablate certain soft tissues.
The cholesterol-lowering drug simvastatin appears to reduce spinal cord injury caused by oxygen deprivation in experimental animals, according to a study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Type 1 diabetes (T1D) patients who have developed low blood sugar (hypoglycemia) as a complication of insulin treatments over time are able to regain normal internal recognition of the condition after receiving pancreatic islet cell transplantation, according to a new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania, published online in Diabetes.
› Verified 1 days ago
Nick Barrentine, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 Quintard Dr, Oxford, AL 36203 Phone: 256-831-6116 | |
Dr. Kai Martin, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 Quintard Dr, Oxford, AL 36203 Phone: 256-831-6116 | |
Roy Hall, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 Snow St, Oxford, AL 36203 Phone: 256-831-7534 Fax: 256-831-4461 | |
Dr. Jeremy Arnold, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 115 Commons Way, Oxford, AL 36203 Phone: 256-835-4080 | |
Tom Hodges, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 92 Plaza Ln, Oxford, AL 36203 Phone: 256-835-0334 | |
Dennis E Wright, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 Snow St, Oxford, AL 36203 Phone: 256-831-7535 Fax: 256-831-4461 | |
Mr. Richard Leslie Samples, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4880 Us Highway 78 W, Oxford, AL 36203 Phone: 256-831-7726 Fax: 256-835-8123 |